CombiMatrix Corporation (NASDAQ: CBMX) is a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal developmental disorders and pre-implantation genetic screening services, according to the company’s website (see here: www.CombiMatrix.com). In this SNNLive On-Location, our host spoke with Mark McDonough, President and CEO of CombiMatrix Corporation in New York City, NY.
In this video interview, Mr. McDonough and our host discuss the following topics:
- Overview of CombiMatrix Corporation
- Size of the market
- Recent news
- How does the company market their services?
- Describes CombiMatrix’s products and services
- Outlook for 2015-2016
Since speaking with Mr. McDonough, the company has made the following announcements:
For more information about CombiMatrix Corporation, go to: www.CombiMatrix.com
© 2017 Stock News Now
Supported by Superior Web Solutions